🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💚 𝙎𝙄𝙀𝙈𝙋𝙍𝙀 𝙏𝙀 𝙇𝙇𝙀𝙑𝙊 𝘾𝙊𝙉𝙈𝙄𝙂𝙊 El lema que UnicajaCB ha llevado por bandera cada día en un año en el que en las gradas del Carpena, cada fin de semana... ha ganado el BALONCESTO. ¡ASÍ LO HA CELEBRADO MÁLAGA! ¡ACABAN LÍDERES DE LA #LigaEndesa! 😃

It’s finally out!! Huge team effort to achieve this results!! Latam united for our patients!! Testing testing and testing is the way to improve our knowledge ⁦⁩Martín Angel⁩ ⁦Pedro C Barata, MD MSc FACP⁩ ⁦GUARD Consortium⁩ AstraZeneca⁩ 👏🏻 ascopubs.org/doi/10.1200/PO…

A pleasure to attend the IV Congrès International - Association Marocaine d’Onco-Urologie #TANGER with Karim Touijer Amina Zoubeidi Elena Castro Alberto Bossi Maha Houssain Antonio Alcaraz and many + colleagues from Morroco and across the world. Great Talks & interacciona

Now available #OpenAccess in Annals of Oncology, recommendations by the ESMO - Eur. Oncology Precision Medicine Working Group for the use of NGS for patients with advanced cancer in 2024 🧬Expanding indications 🧬CUP & tissue-agnostic situations 🧬Best practice annalsofoncology.org/article/S0923-…

📢Updated ESMO recommendations for the use of NGS in guiding treatment decision for patients with advanced cancer in 2024 annalsofoncology.org/article/S0923-…

When to perform an NGS test in cancer patients? dailyreporter.esmo.org/news/when-to-p…

¡Nuestra escuela de pacientes de tumores torácicos regresa mañana con mucha ilusión! 🙌 Gracias a Oncosur por su enorme esfuerzo en la investigación, humanización de los cuidados y también en la formación de pacientes. Te esperamos! Cáncer de Pulmón Asociación Española Contra el Cáncer oncosur.org/actividades-pa…

TRIUMPH study: First trial to show that PARP inhibition can work in the absence of ADT (hormone-sparing approach) for men with germline HRR-altered mHSPC, esp. for gBRCA2! Congrats to Mark C. Markowski for leading this paradigm-shifting trial. Cathy Handy Marshall, MD MPH academic.oup.com/oncolo/advance…

🎯 El simposio anual 🔥🔥GUARD Consortium se acerca! Excelente programa de ponentes y workshops multidisciplinares!!👇 🗓️ 26-27 junio (presencial/online) 📍 Sede: espacioMaldonado (Madrid) (presencial/online) Inscripciones gratuitas contactar: [email protected] 🧵Ver

🎯 Starting GUARD symposium discussing the multidisciplinar management of GU Pathology! 💃Kristof V URONCOR GUO-AEU SEMNIM S.E.F.H ASEICA OncoAlert UroTarget CLOC: Curso Latinoamericano de Oncología Clínica

ESMO recommendations to homogenize NGS reports. Important to enhance physicians’ comprehension of genomic findings and facilitate clinical decision making. Annals of Oncology ESMO - Eur. Oncology annalsofoncology.org/article/S0923-…

🆒Clin Obs GU cancer program! Proud to coordinate with Daniel Castellano 2 weeks ago 📖Both theoretical and practical 🎤Highly interactive, 25 physicians from all over the world at our Hospital 😃Great success! 📻Stay tuned for more national & international editions 🔴Thanks MSD España

🎯🎯 a great GU multidisciplinary program including Lab training (Elena Castro David Olmos) a Nuclear Medicine course (#adolfogomez SEMNIM) and simulation practice based pts (Félix Guerrero-Ramos). Thanks a global @MSD support!

I enjoyed my visit to the GU Cast studio for the recording of the Prostate Cancer Olympics 2024 podcast with Arun Azad , Declan Murphy and Renu Eapen. We had some discrepancies about the gold medalists, which would your winners? GU Cast | Urology podcast! youtu.be/6NqT9z1c8aw?si…

🎯😎🎯😎… finally HABEMUS ESMO - Eur. Oncology football 2024 tournament!! #ESMO24 Toni Choueiri, MD FabriceAndre ASCO ⚽️🥅🏆🏆 👉 Saturday 14-9 - 6.00 to 10.00 PM🔥🔥 - Some Teams are registered! USA- France- Spain- Brasil -Argentina -Colombia - Pending Germany? Peru? UK? Australia? -

Location is here👇👇👇

tenemos 2 ofertas abiertas para tecnic@s de laboratorio en nuestro laboratorio de Vall d’Hebron Institute of Oncology (VHIO) - una para trabajar en NGS/biopsia liquida y otra para trabajar con modelos PDX y experimentos in vivo - se agradece difusión :-) vhio.net/2024/09/06/ref… vhio.net/2024/09/02/202…

PFS and OS advantage of radium-223 + Enza vs Enza alone in metastatic prostate cancer—-new combo on the horizon —congrats silke gillessen and PEACE-3 team. No increased SREs! ESMO - Eur. Oncology #ESMO2024

First results of PARPi+ARPi in mHSPC. ZZ First shows rPFS advantage from combining Talazoparib + Enza vs Enza in unselected pts #ESMO24